publication date: Sep. 20, 2013
Vol. 39, No. 35 – Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals HHS, NIH Prepare for Government Shutdown FDA Approves Generic Capecitabine
Download the PDF
Documents referenced in this issue of The Cancer Letter can be found here
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.